글로벌 전신성 아스페르길루스증 및 전신성 칸디다증 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 전신성 아스페르길루스증 및 전신성 칸디다증 시장

전신성 아스페르길루스증 및 전신성 칸디다증 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 4.00%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다.

전신성 아스페르길루스증과 전신성 칸디다증은 곰팡이 감염의 한 유형입니다. 아스페르길루스증은 아스페르길루스에 의해 발생하는 심각한 폐 감염이며 주로 개인의 호흡 기관에 영향을 미칩니다. 아스페르길루스는 주로 면역 체계가 약하거나 폐 감염이 있는 사람들에게 영향을 미치는 일반적인 곰팡이입니다. 이러한 심각한 곰팡이 감염은 AIDS, 천식 , 장기 이식, 암 및 코르티코스테로이드 요법 과 같은 건강 문제로 인해 발생합니다 .

진균성 질환의 유병률 증가, 의료비 지출 증가, 치료 옵션 개발, 병원 내 진균 감염 증가, 정부 자금 지원 증가, 질병에 대한 인식을 확산하기 위한 정부 및 민간 기관의 이니셔티브 증가는 전신성 아스페르길루스증 및 전신성 칸디다증 시장을 확대할 요인입니다. 또한 암 , 천식, 만성 폐쇄성 폐질환 및 결핵의 증가는 시장 성장을 증가시킬 주요 원동력입니다.

2021~2028년 예측 기간 동안 연구 개발 활동과 신약 파이프라인의 증가는 전신성 아스페르길루스증 및 전신성 칸디다증 시장에 유익한 기회를 제공할 것입니다.

그러나 높은 치료 비용, 항진균제와 관련된 부작용, 항진균제에 대한 내성 증가 등은 시장 성장을 방해하는 요인들이고, 위에서 언급한 예측 기간 동안 전신성 아스페르길루스증 및 전신성 칸디다증 시장을 더욱 어렵게 만들 것입니다.

This systemic aspergillosis and systemic candidiasis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the systemic aspergillosis and systemic candidiasis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Systemic Aspergillosis and Systemic Candidiasis Market Scope and Market Size

The systemic aspergillosis and systemic candidiasis market is segmented on the basis of type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the systemic aspergillosis and systemic candidiasis market is segmented into voriconazole, systemic oral azoles, topical antifungal agents, liposomal amphotericin B and others.
• On the basis of application, the systemic aspergillosis and systemic candidiasis market is segmented into genitourinary tract candidiasis, allergic bronchopulmonary aspergillosis (ABPA), gastrointestinal candidiasis, chronic pulmonary aspergillosis (CPA) and others.
• On the basis of end-users, the systemic aspergillosis and systemic candidiasis market is segmented into clinic, hospital and others.

The systemic aspergillosis and systemic candidiasis market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Systemic Aspergillosis and Systemic Candidiasis Market Country Level Analysis

Systemic aspergillosis and systemic candidiasis market is analyzed and market size information is provided by the country, type, application, end-users and distribution channel as referenced above.

The countries covered in the systemic aspergillosis and systemic candidiasis market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the systemic aspergillosis and systemic candidiasis market due to the presence of major key players, growing investment for R&D activities, high disposable income, high healthcare expenditure and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, increase in the prevalence of fungal infection, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Systemic aspergillosis and systemic candidiasis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Systemic Aspergillosis and Systemic Candidiasis Market Share Analysis

Systemic aspergillosis and systemic candidiasis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to systemic aspergillosis and systemic candidiasis market research.

전신성 아스페르길루스증 및 전신성 칸디다증 시장 보고서에서 다루는 주요 기업으로는 Sanofi, Novartis AG, Merck Sharp & Dohme Corp., Pfizer Inc., Bayer AG, Astellas Pharma Inc., GlaxoSmithKline plc, Abbott, Cipla Inc., Enzon Pharmaceuticals, Inc., Squibb Company, Mylan NV, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, MACHEREY-NAGEL GmbH & Co. KG, Taj Pharmaceuticals Limited, Genentech, Inc., Cilag AG, DAIICHI SANKYO COMPANY, LIMITED, Sandoz International GmbH 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-66552